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Abstract 
 
 
 The aim of the present study was to evaluate the effects of aqueous seed extract of Tephrosia purpurea 
(TpASet) on blood glucose and antioxidant status in streptozotocin induced diabetic rats. Hyperglycemia associated 
with an altered hexokinase and glucose-6-phosphatase activities, elevated lipid peroxidation, disturbed enzymatic 
[Superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx)] and non enzymatic [Glutathione, 
vitamin C and vitamin E] antioxidant status were observed in streptozotocin induced diabetic rats. Oral 
administration of “TpASet” at a dose of 600mg/kg body weight showed significant improvement in above mentioned 
parameters. Our results clearly indicate that “TpASet” has potent antihyperglycemic and antioxidant effects in 
streptozotocin-induced diabetic rats and therefore further studies are warranted to isolate and characterize the 
bioactive principles from “TpASet”. 
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Introduction 
 
 Diabetes mellitus is a clinically and genetically heterogeneous group of disorders, characterized by 
abnormally high blood glucose concentration, Hyperglycemia is due to deficiency of insulin secretion or resistance 
of the body cells to the action of insulin, often associated with carbohydrate, protein and lipid metabolism. These 
metabolic disturbances result in acute and long term diabetic complications, which are responsible for premature 
death and disability. According to World health organization, approximately more than 100 million peoples were 
reported to have diabetes mellitus worldwide (Zimmet, 1999). India is one of the leading countries with high number 
of people with diabetes mellitus and it is estimated that around 57 million peoples will be suffering  from diabetes 
mellitus by the year 2025 (Aravind et al., 2002). 
 Oxygen free radicals have been implicated in the pathogenesis of various disorders including diabetes 
mellitus. Oxygen free radicals are formed by auto oxidation of glucose and non enzymatic glycation of proteins. It is 
well documented that diabetes is associated with increased oxidative stress as evidenced by the increased 
accumulation of lipid peroxides (Maritim et al., 2003). Under physiological conditions antioxidant defense system 
protects the body against adverse effects of free radical generation.  In diabetes mellitus hyperglycemia may depress 
the natural antioxidant system. Elevated generation free radicals resulting in the consumption of antioxidant defense 
components may lead to disruption of cellular functions and oxidative damage to membranes and may enhance 
susceptibility to lipid peroxidation. Several reports indicate that modified oxidative stress is due to chronic 
hyperglycemia (Bhor et al., 2004). Enzymatic antioxidants form the first line of antioxidant defense mechanism to 
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protect the organism from reactive oxygen species mediated oxidative damage (Santhakumari et al., 2003). Enhanced 
oxidative stress has been well documented in both experimental and human diabetes mellitus (Baynes, 1991). 
Streptozotocin induced diabetes mellitus is an ideal model to study the beneficial effects of investigating 
agents. World health organization has suggested that medicinal plants may provide valuable therapeutics agents in 
modern medicine and in traditional system, especially in areas where the modern drugs are unavailable (World 
Health Organization, 1994). Oral hypoglycemic agents such as metformin and sulphonylureas have to be given 
through out life time and produce side effects like hypoglycemia (Dixit and Joshi, 1985). Folk medicine in India 
describes several kinds of indigenous herbs and plants belonging to various families to be recommended for the 
treatment of diabetes mellitus. There are several reports which strongly recommended for hypoglycemic and 
antihyperglycemic effects of different medicinal plants (Bordia et al., 1997); Upadhya et al., 2004). Tephrosia 
purpurea, commonly known as “Sarapunkha” in Sanskrit and “Purple tephrosia” in English, is widely used in 
Ayurveda and Siddha medicines to treat various disorders like jaundice, kidney disorders and to reduce thirst in 
diabetes mellitus (Joshi, 2000; Kritikar and Basu, 1956). However, we have not found any studies on the 
antihyperglycemic and antioxidants effects of T. Purpurea in experimental diabetes mellitus. Thus, in the present 
study, we have evaluated the antihyperglycemic and antioxidant effects of T. purpurea in streptozotocin induced 
diabetic rats. 
 
 
Materials and Methods 
Plant material 
 
 Seeds of T. purpurea were collected in and around Chidambaram, Tamil Nadu and it was botanically 
authenticated. A voucher specimen (AU05102) was deposited in the Department of Botany, Annamali University, 
Annamalai nagar, Tamilnadu. 
 
Preparation of plant extract 
 
About 100g of fine powder of T. purpurea seeds was suspended in 250 ml of water for 2 hrs and then 
heated at 60-65oC for 30 min. The extract was preserved and the process was repeated three times with the residual 
powder, each time collecting the extract. The collected extract was pooled and passed through fine cotton cloth. 
Filtrate upon evaporation at 40-50oC yielded 13% semisolid extract. This was stored at 0-4oC until used. 
 
Animals 
  
Albino Wistar male rats 7 to 8 weeks old and weighing 150-200g were used for the present study. The 
animals were obtained from central animal house, Rajah Muthiah Institute of Health Sciences, Annamalai 
University, India and were housed in the central animal house with 12 light and 12 h dark cycles. The animals were 
randomized into experimental and control groups and housed 4 or 5 in a polypropylene cages. Standard pellets 
obtained from Mysore Snack Feed Ltd, Mysore, India, were used as a basal diet during the experiment. The control 
and experimental animals were provided food and drinking water ad libitum. We got ethical committee clearance for 
our animal experimental design (House registration number 160/1999/CPCSEA and approval date 25-08-2003). 
 
Induction of diabetes mellitus 
  
 Diabetes mellitus was induced in Wistar rats by single intraperitoneal injection of streptozotocin (50mg/kg 
bw) dissolved in 0.1M citrate buffer (pH 4.5) to overnight fasted Albino Wistar rats (Chang, 2000). The diabetes was 
assessed in streptozotocin induced rats by determining the blood glucose concentration, 48 hours after injection of 
streptozotocin. The rats with blood glucose level above 250 mg/dl were selected for the experimental studies. 
 In the experiment, a total number of 30 rats (18 diabetic rats, 6 normal rats 6 normal rats treated with 
“TpASet” alone) were used. The rats were divided into 5 groups of six each. 
 
Group I : Served as control rats and did not receive any other treatment 
Group II : Diabetic control (50mg/kg bw i.p streptozotocin) 
Group III: Diabetic rats receiving “TpASet” (600 mg/kg bw) using an intragastric tube daily for 45 days 
Group IV: Control rats receiving “TpASet” (600 mg/kg bw) using an intragastric tube daily for 45 days 
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Group V : Diabetic rats receiving glibenclamide (600 µg/kg bw) in distilled water using an intragastric tube 
daily for 45 days. 
 
 After the experimental period, all animals were sacrificed by cervical dislocation and biochemical studies 
were conducted on plasma, liver and kidney of control and experimental animals in each group.  
 Blood glucose (Sasaki et al., 1972) glycosylated hemoglobin (Sudhakar Nayak. and Pattabiraman, 1981), 
total hemoglobin (Drabkin and Austin, 1932) and plasma insulin (Anderson et al., 1993) were estimated. TBARS in 
plasma (Yagi, 1987) and tissues (Ohkawa et al., 1979) were assayed. Hydroperoxides  (Jiang et al., 1992) was 
estimated. Superoxide dismutases (Kakkar et al., 1984), catalase (Sinha, 1972) and glutathione peroxidase (Rotruck 
et al., 1984) were estimated and reduced glutathione (Beutler and Kelly, 1963), vitamin C (Omaye et al., 1979) 
vitamin E (Desai et al., 1984) were estimated. Hexokinase (Brandstrup et al., 1957) and glucose-6-phosphatase 
(Koida and Oda, 1959) activities in liver were estimated.   
 
Analysis 
  
The data were expressed as mean±SD.  Statistical comparisons were performed by one way analysis of 
variance [ANOVA] followed by Duncan’s multiple range test [DMRT]. The results were considered statistically 
significant if the p values were 0.05 or less. 
 
 
Results 
 
 Table 1 shows the blood picture of control and experimental animals in each group. The levels of blood 
glucose and glycosylated hemoglobin were significantly increased (p<0.05) whereas the levels of plasma insulin and 
total hemoglobin were significantly decreased (p<0.05) in streptozotocin induced diabetic animals as compared to 
control animals. However, the above said parameters were significantly improved (p<0.05 ) in diabetic rats treated 
with “TpASet” and glibenclamide. 
 
 
Table 1:  Blood picture of control and experimental animals in each group. 
 
Groups 
 
Blood glucose 
(mg/dl) 
 
Glycosylated hemoglobin 
(HbA1%) 
 
 
Total hemoglobin 
(grams/dl) 
 
Plasma  
Insulin 
 (µU/ml) 
 
Control 
 
 
82.5 ±5.28a 
 
 
 
2.92 ±0.18a 
 
13.9 ±1.06a 
 
14.2 ±1.11a 
 
Diabetes control 
 
 
284.6 ±20.7b 
 
6.02 ±0.49b 
 
8.2 ±0.67b 
 
8.2 ±0.91b 
 
Diabetes + TpASet 
(600mg/kg bw) 
 
 
140.5 ±13.6c 
 
4.86 ±0.32c 
 
9.8 ±10c 
 
10.7±1.30c 
 
Control + TpASet 
(600mg/kg bw) 
 
 
80.2 ±5.9a 
 
2.80 ±0.16a 
 
13.8 ±1.02a 
 
14.4 ±1.14a 
Diabetes + glibenclamide 
(600µg/kg bw) 
 
 
128.2 ±11.9d 
 
4.32±0.26d 
 
11.1 ±1.14d 
 
12.4±1.09d 
Values are expressed as mean ± SD (n=6)   
Values not sharing a common superscript letter differ significantly at p<0.05(DMRT) 
TpASet : Tephrosia purpurea aqueous seed extract 
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Table 2: Activities of hexokinase and glucose-6-phosphatase in the liver of control and experimental  animals in 
each group.  
 
Groups 
 
 
Hexokinase 
(U*/mg protein) 
 
Glucose-6-phosphatase 
 (U**/mg protein) 
 
Control 
 
 
0.25 ±0.03a 
 
 
 
2.53 ±0.14a 
 
Diabetes control 
 
 
0.12 ± 0.02b 
 
3.90 ±0.36b 
 
Diabetes + TpASet 
(600mg/kg bw) 
 
 
0.16 ±0.02c 
 
3.46 ±0.26c 
 
Control + TpASet (600mg/kg bw) 
 
 
0.26. ±0.03a 
 
2.46 ±0.19a 
 
Diabetes + glibenclamide (600µg/kg bw) 
 
 
0.18 ±0.01d 
 
3.08±0.31d 
Values are expressed as mean ± SD (n=6 rats) ; Values not sharing a common superscript letter differ significantly at 
p<0.05(DMRT); * - Micromoles of glucose phosporylated/hour; ** - Micromoles Pi liberated/min 
TpASet : Tephrosia purpurea aqueous seed extract 
 
 Table 2 indicates the activities of hexokinase and glucose-6-phosphatase in the liver of control and 
experimental animals in each group. A significant decrease (p<0.05) in hexokinase and increase (p<0.05) in glucose-
6-phosphatase activities were noticed in the liver of diabetic animals as compared to control animals. Oral 
administration of “TpASet” to diabetic animals reverted  the enzyme activities to near normal concentrations. Table 
3 shows the levels of TBARS, hydroperoxides, vitamin C and vitamin E in plasma of control and experimental 
animals in each group. The levels of TBARS and hydroperoxides were significantly (p<0.05) increased whereas 
vitamin C and E levels were decreased in diabetic animals. The levels of TBARS and hydroperoxides, vitamin C and 
E levels were significantly (p<0.05) improved in diabetic animals treated with “TpASet Table 4 presents the levels 
TBARS and hydroperoxides in liver and kidney of control and experimental animals in each group. The levels of 
TBARS and hydroperoxides were significantly (p<.0.05) increased in diabetic animals compared to control animals. 
Oral administrations of “TpASet” at a dose of 600mg/kg bw reverted the levels of TBARS and hydroperoxides in 
diabetic animals. 
 Table 5 and 6 indicate the concentration of GSH and the activities of enzymatic antioxidants such as SOD, 
CAT and GPX in the liver and kidney of control and experimental animals in each group. Activities of these 
enzymes and GSH level significantly (p<0.05) decreased in diabetic animals compared with control. The activities of 
these enzymes were significantly (p<0.05) improved in diabetic animals treated with “TpASet”. Rats administered 
with “TpASet” alone did not produce any significant alteration in plasma and tissue antioxidant parameters. 
 
 
 
Discussion  
 
 Hyperglycemia is associated with the development of micro and macrovascular complications. 
Streptozotocin, a naturally occurring nitrosamide, damages pancreatic β-cells possibly by generating excess reactive 
oxygen species and thus widely used for the induction of diabetes mellitus in experimental models. Streptozotocin 
generated lipid peroxidation and DNA breaks in pancreatic islet cells have been demonstrated (Takasu et al., 1991). 
Oxidative stress is an imbalance between the formation of free radicals and the rate at which they are scavenged by  
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Table 3: Levels of TBARS, Hydroperoxides, Vitamin C and Vitamin E in plasma of control and    experimental  
animals in each group. 
 
Groups 
 
TBARS 
 n mol/ml 
 
Hydroperoxides (mmol/ml) 
 
 
Vitamin C (mg/dl) 
 
Vitamin E  
(mg/dl) 
 
Control 
 
 
1.86 ±0.16a 
 
 
 
0.54 ±0.04a 
 
1.78 ±0.14a 
 
1.38 ±0.09a 
 
Diabetes control 
 
 
3.05 ±0.31b 
 
0.84 ±0.09b 
 
1.12±0.11b 
 
0.78 ±0.13b 
 
Diabetes + TpASet 
(600mg/kg bw) 
 
 
2.56 ±0.19c 
 
0.64 ±0.06c 
 
1.38 ±0.15c 
 
1.02±0.09c 
 
Control + TpASet (600mg/kg bw) 
 
 
1.75 ±0.13a 
 
0.52 ±0.04a 
 
1.80 ±0.11a 
 
1.42 ±0.11a 
 
Diabetes + glibenclamide (600µg/kg bw) 
 
 
2.12 ±0.27d 
 
0.59±0.03d 
 
1.52 ±0.12d 
 
1.15±0.06d 
Values are expressed as mean ± SD (n=6).  Values not sharing a common superscript letter differ significantly at 
p<0.05(DMRT); TpASet : Tephrosia purpurea aqueous seed extract 
 
Table 4: Levels of TBARS Hydroperoxides, in liver and kidney of control and experimental animals in each group. 
 
LIVER 
 
 
KIDNEY 
 
 
 
 
Groups 
 
 
TBARS 
(mmol/100g protein) 
 
Hydroperoxides 
(mmol/100g protein)  
 
 
TBARS 
(mmol/100g protein) 
 
Hydroperoxides 
(mmol/100g  
protein)  
 
Control 
 
 
1.20 ±0.07a 
 
 
 
68.24±3.5a 
 
1.40 ±0.11a 
 
54.38± 4.82a 
 
Diabetes control 
 
 
3.82 ±0.42b 
 
98.52 ± 6.24b 
 
4.10 ± 0.38b 
 
85.42 ± 6.30b 
 
Diabetes + TpASet 
(600mg/kg bw) 
 
 
2.94 ±26c 
 
78.64 ± 5.42c 
 
2.78 ±0.22c 
 
66.83±5.42c 
 
Control + TpASet 
(600mg/kg bw) 
 
 
1.14 ±0.09a 
 
66.82 ±4.35a 
 
1.38 ±0.14a 
 
52.18±4.26a 
 
Diabetes + glibenclamide 
(600µg/kg bw) 
 
 
2.52 ±0.22d 
 
72.43±0.38d 
 
2.40±0.17d 
 
61.25±5.14d 
Values are expressed as mean ± SD (n=6).  Values not sharing a common superscript letter differ significantly at 
p<0.05(DMRT); TpASet : Tephrosia purpurea aqueous seed extract. 
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Table 5: Level of GSH and activities of SOD, CAT and GPx  in liver of control and experimental animals in each 
group. 
 
 
Groups 
 
GSH 
 (mg/100g  
tissue) 
 
SOD  
(unitA /mg protein) 
 
 
Catalase 
 (unitB /mg protein) 
 
 
GPx 
(unitC/mg  
protein) 
 
 
Control 
 
 
13.76 ±1.12a 
 
 
 
10.64±0.73a 
 
70.5 ±6.1a 
 
5.90±0.37a 
 
Diabetes control 
 
 
8.50±1.1b 
 
6.05±0.59b 
 
 
29.6±3.8b 
 
 
3.60±0.39b 
 
 
Diabetes + TpASet 
(600mg/kg bw) 
 
 
10.95 ±0.96c 
 
7.85±0.86c 
 
 
43.2 ±4.9 
 
 
4.37 ±0.41c 
 
 
Control + TpASet (600mg/kg 
bw) 
 
 
13.90 ±1.05a 
 
11.02±0.69a 
 
 
72.2 ±5.4a 
 
 
6.02 ±0.45a 
 
 
Diabetes + glibenclamide 
(600µg/kg bw) 
 
 
12.80±0.87a 
 
9.02±0.73d 
 
 
50.1±3.6d 
 
 
5.02 ±0.42d 
 
Values are expressed as mean ±SD (n=6).  Values not sharing a common superscript letter differ significantly at 
p<0.05(DMRT); AThe amount of enzyme required to inhibit 50% NBT reduction; BMicromoles of H2O2 utilized/min 
CMicromoles of glutathione utilized/min; TpASet : Tephrosia purpurea aqueous seed extract. 
 
 
 enzymatic and non enzymatic antioxidants in diabetes. Lipid peroxidation is one of the characteristic features of 
diabetes mellitus. In diabetes red blood cells were more susceptible to lipid peroxidation. Measurement of plasma 
thiobarbituric acid reactive substances (TBARS) was used as an index of lipidperoxidation and it helps to assess the 
extent of tissue damage (Gutteridege, 1995). Several studies have reported an increase in TBARS and 
hydroperoxides in plasma, liver and kidney in experimental diabetes mellitus. (Ananthan et al., 2004; Venkateswaran 
and Pari, 2002) Our results corroborate these observations. 
 Glutathione is a tripeptide, intracellular antioxidant and protects the cellular system from adverse effects of 
lipid peroxidation. In diabetic rats we have found that lower levels of GSH in tissues which indicate increased 
utilization due to oxidative stress. Previous studies reported that hyperglycemia induces polyol pathway that 
consumes NADPH which is necessary for GPx redox cycle (Subbiah Rajasekaran et al., 2005). GPx is a selenium 
containing antioxidant which plays crucial role in scavenging toxic free radicals by using GSH as substrate. 
Decreased GPX activity in diabetic rats  is probably due to insufficiency of GSH. Vitamin E is one of the most 
important free radical scavenging chain-breaking antioxidant in the cell membrane (Parks and Traber, 2000). In 
diabetes, disturbances in ascorbic acid metabolism might have a great role in the pathogenesis of diabetic 
complications (Gumieniczek et al., 2002). In the present study we noticed decreased plasma vitamin C and E levels 
in diabetic rats which represent increased utilization by elevated oxidative stress or decreased GSH level since GSH 
is required for recycling of vitamin C. Bode et al (1993) reported that reduced activity glucose-6-phosphate 
dehydrogenase in diabetes, which produces NADPH to regenerate ascorbate from dehydrogenase. SOD protects 
from oxygen free radicals by catalyzing the removal of superoxide radical, which damage the membrane and 
biological structures. Catalase was shown to be responsible for the detoxification of H2O2, (Mahboob et al., 2005). In 
the present study we observed decreased SOD and catalase activities in diabetic rats. This may result in number 
deleterious effects due to accumulation of superoxide radical and H2O2. 
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Table 6: Level of GSH and activities of SOD, CAT and GPx  in kidney of control and experimental animals in each 
group. 
 
Groups 
 
GSH 
 (mg/100g  
tissue) 
 
SOD  
(unitA/mg protein) 
 
 
Catalase 
 (unitB/mg protein) 
 
 
GPx 
(unitC /mg  
protein) 
 
 
Control 
 
 
8.26 ±0.72a 
 
 
 
13.65±0.99a 
 
38.26 ±2.51a 
 
6.40±0.37a 
 
Diabetes control 
 
 
4.65±0.55b 
 
8.50±0.78b 
 
18.80±1.93b 
 
3.40±0.32b 
 
Diabetes + TpASet 
(600mg/kg bw) 
 
 
6.04±0.61c 
 
10.23 ±1.1c 
 
22.61 ±2.25c 
 
4.42±0.52c 
 
Control + TpASet (600mg/kg 
bw) 
 
 
8.75±0.58a 
 
 
13.80±0.96a 
 
 
40.18 ±3.06a 
 
 
6.51±0.41a 
 
 
Diabetes + glibenclamide 
(600µg/kg bw) 
 
 
6.94 ±0.45d 
 
 
11.64 ±0.92d 
 
 
27.42 ±2.01d 
 
 
5.12±0.46d 
 
               Values are expressed as mean ±SD (n=6)   
               Values not sharing a common superscript letter differ significantly at p<0.05(DMRT) 
                         AThe amount of enzyme required to inhibit 50% NBT reduction,  BMicromoles of H2O2 utilized/min 
                         CMicromoles of glutathione utilized/min; TpASet : Tephrosia purpurea aqueous seed extract 
 
 In the current study, we observed that administration of“TpASet” to diabetic rats at a dose of 600mg/kg 
body weight for 45 days resulted in decrease in the blood glucose concentration and also increased insulin level 
which could be due to the stimulation of insulin secretion from remnant pancreatic β-cells which in-turn enhance 
glucose utilization by peripheral tissues. Glycosylated hemoglobin reflects the mean blood glucose concentration. 
Hence HbAIC is now considered as the most reliable marker of glycemic control in diabetes mellitus (Latha and Pari, 
2004). In diabetes, high blood glucose reacts with hemoglobin and  thus increased glycosylated hemoglobin are 
formed. We observed decreased hemoglobin and increased glycosylated hemoglobin levels in diabetic rats. Increased 
hemoglobin in “TpASet” treated diabetic rats indicated decreased blood glucose level and glycosylated hemoglobin. 
Decrease in hexokinase and increase in glucose-6-phosphatase activities were noticed in the liver of diabetic animals 
as compared to control animals. Oral administration of “TpASet” to diabetic animals which significantly improved 
hexokinase and glucose-6-phosphatase activities, which suggest its stimulatory effects on glycolysis and inhibitory 
action on gluconeogenesis in diabetes mellitus. The observed increase in antioxidant activities and decline in TBARS 
and hydroperoxides in “TpASet” treated diabetic rats suggesting its potent antilipid peroxidative and antioxidant 
effects.  Furthermore the plant drug was found to be as effective as that of the reference drug glibenclamide. 
Although the plant drug has considerable blood glucose lowering effect, the effect was much lesser than 
that of glibenclamide, the reference drug. 
 
 
Conclusion 
 
 In conclusion, the results of the present study showed that the aqueous seed extract of Tephrosia purpurea 
have blood glucose lowering effects and it also had potent antioxidant properties, which may contribute towards 
preventing peroxidative damage.  
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